This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...

CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell. After that ...

CRISPR stock offers bold investment potential and how strategic portfolio management can boost resilience and long-term wealth. Learn more on CRSP stock here.

CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...

For years, researchers have been trying to figure out how to treat inherited blood disorders like sickle cell disease without causing new health problems in the process. Now, a team of scientists from ...

A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like sickle cell, while also proving beyond doubt that chemical tags on DNA—often ...

Researchers demonstrate the active role methyl groups play in silencing genes, demonstrating the therapeutic potential of ...

Scientists have achieved the first DNA-free CRISPR gene editing in raspberries, reaching 19% efficiency and opening the door to faster breeding of firmer, more resilient berries — though regenerating ...

Bar-Ilan University scientist part of €8 million consortium to ensure accuracy in CAR-T cell therapy, an immunotherapy using CRISPR-Cas9, in European hospitals ...

NtRON Bio announced today, following its recent U.S. patent application related to colorectal cancer using the IMPA™ phage engineering technology, it has now completed the filing of two patents for a ...